Vistagen Therapeutics, Inc.

VTGN

Vistagen Therapeutics, Inc.

VTGN

Insider Sentiment (TTM):

Last Purchase:2023-08-07Last Sale:2022-07-12Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:13,961,650Shares Outstanding:38,073,926Institutional Ownership Pct.:36.67%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	17	31	47	63	49	67	75	84	103	119	127	38
Available For Sale Securities Debt Securities Curr…	15	15	14	14	14	13	14	13	5	0	-	-
Prepaid Expense And Other Assets Current	3	2	1	2	4	2	1	2	2	2	1	1
Deferred Costs Current	-	-	-	-	-	-	-	-	-	0	0	0
Assets Current	34	47	63	79	67	82	90	100	111	121	128	39
Property Plant And Equipment Net	0	0	0	1	1	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	1	1	1	1	1	1	1	2	2	2	2	2
Other Assets Noncurrent	0	0	0	0	0	0	0	0	1	1	-	-
Deferred Costs	-	-	-	-	-	-	-	-	-	0	0	0
Assets	36	49	65	81	69	84	92	102	114	124	131	42
Liabilities And Stockhold…
Deposits Assets Noncurrent	-	-	-	-	-	-	-	-	-	0	0	0
Accounts Payable Current	1	2	1	2	0	1	1	1	1	2	2	1
Accrued Liabilities Current	9	9	9	8	7	9	5	4	2	2	0	0
Notes Payable	-	0	-	-	-	0	-	-	-	-	-	-
Notes Payable Current	0	-	0	1	1	-	-	-	-	0	-	-
Contract With Customer Liability Current	0	2	2	2	3	3	3	2	2	1	2	1
Operating Lease Liability Current	1	1	1	1	1	1	1	1	1	1	1	1
Finance Lease Liability Current	-	-	-	-	-	-	-	-	-	-	0	0
Liabilities Current	11	13	14	14	11	13	10	8	6	5	4	3
Liabilities Noncurrent
Contract With Customer Liability Noncurrent	0	0	0	0	0	0	0	1	1	3	2	2
Operating Lease Liability Noncurrent	0	0	0	1	1	1	1	1	1	2	2	2
Finance Lease Liability Noncurrent	-	-	-	-	-	-	-	-	-	-	0	0
Liabilities Noncurrent	-	-	-	-	-	-	-	-	-	-	-	4
Liabilities	11	13	14	15	12	14	11	10	9	9	8	7
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	519	517	516	512	483	482	479	477	476	474	474	380
Treasury Stock Common Value	-4	-4	-4	-4	-4	-4	-4	-4	-4	-4	-4	-4
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	0	0	0	0	0	0	0	-	-
Retained Earnings Accumulated Deficit	-490	-477	-461	-442	-423	-408	-394	-380	-367	-356	-347	-340
Stockholders Equity	24	36	51	66	57	70	81	93	105	114	123	36
Liabilities And Stockholders Equity	36	49	65	81	69	84	92	102	114	124	131	42
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	-	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	-	10
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	-	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	-	0.001
Common Stock Shares Authorized	325	325	325	325	325	325	325	325	325	325	-	325
Common Stock Shares Issued	44	40	40	39	29	29	27	27	27	27	27	12
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	0	-	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2027	-	-	-	-	-	-	-	-	-	-	-	-
2026	22.34%	29.30%	49.08%	13.95%	-82.11%	-85.26%	10.91%	7.27%	14.55%	-54.39%	-49.12%	-
2025	-4.13%	-11.21%	-8.26%	-8.97%	-17.63%	-5.45%	-3.16%	-17.54%	-16.49%	0.00%	24.79%	49.16%
2024	-	-	-	26.30%	77.85%	67.82%	-14.08%	2.86%	-8.16%	-9.81%	-15.65%	-7.43%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.07	3.67	4.67	5.79	5.98	6.51	9.35	13.29	17.77	23.55	30.76	13.43
Quick Ratio	2.84	3.55	4.57	5.66	5.66	6.38	9.20	12.97	17.38	23.26	30.41	12.95
Working Capital	23.12M	34.15M	49.72M	65.29M	55.56M	69.46M	80.32M	92.43M	104.60M	115.55M	123.95M	36.17M
Leverage & Debt
Debt to Equity	0.46	0.37	0.28	0.22	0.21	0.20	0.14	0.10	0.08	0.08	0.06	0.18
Interest Coverage TTM	-34.00	-29.55	-24.59	-20.29	-15.41	-12.28	-10.10	-7.96	-8.20	-9.85	-18.46	-116.26
Debt Ratio	0.31	0.27	0.22	0.18	0.18	0.17	0.12	0.09	0.08	0.08	0.06	0.16
Efficiency & Turnover
Asset Turnover TTM	0.05	0.02	0.01	0.01	0.01	0.00	0.01	0.01	0.02	0.01	0.00	-0.00
Per Share Metrics
Diluted EPS TTM	-1.57	-1.83	-1.59	-1.74	-1.75	-1.67	-1.54	-1.29	-1.08	-1.52	-1.09	-3.53
Free Cash Flow Per Share TTM	-1.89	-1.38	-1.10	-1.10	-0.55	-1.36	-1.27	-1.09	-0.94	-1.33	-0.89	-3.14
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-2,785.69%	-5,683.69%	-8,847.85%	-9,080.72%	-9,233.13%	-11,517.08%	-7,558.94%	-5,205.59%	-3,929.35%	-3,103.48%	-22,706.70%	43,585.38%
Net Profit Margin TTM	-2,703.72%	-5,491.33%	-8,486.84%	-8,631.90%	-8,634.67%	-10,579.84%	-6,767.38%	-4,516.55%	-3,418.33%	-2,759.59%	-21,478.90%	43,214.62%
Growth Metrics
Net Revenue Growth (1Y)	287.15%	161.11%	13.02%	-17.69%	-33.47%	-54.32%	368.18%	-1,166.99%	-369.65%	-568.72%	-83.09%	-107.74%
Net Income Growth (1Y)	21.23%	35.53%	41.73%	57.30%	68.05%	75.12%	47.51%	11.52%	-28.43%	-50.44%	-50.11%	-45.46%
EPS Growth (1Y)	-9.94%	9.91%	3.07%	34.79%	61.07%	9.77%	41.15%	-63.44%	-82.84%	-82.18%	-88.30%	-62.56%
Valuation Metrics
P/E TTM	-0.15	-0.31	-0.42	-2.04	-1.14	-1.50	-1.92	-2.33	-3.21	-3.48	-4.71	-1.48
P/B TTM	0.40	0.61	0.55	1.91	1.13	1.10	1.12	0.99	1.02	0.89	1.23	1.48
P/S TTM	3.95	17.10	35.28	176.02	98.86	158.83	129.61	105.25	109.68	96.04	1,011.75	-640.96
Market Cap	9.89M	21.70M	27.87M	126.91M	63.86M	77.19M	90.60M	92.20M	106.50M	102.19M	151.05M	52.62M
Enterprise Value	-7.11M	-8.99M	-19.12M	64.78M	15.81M	10.06M	15.89M	7.96M	3.58M	-16.97M	24.50M	15.02M
Calculated Values
Free Cash Flow TTM	-81.14M	-52.68M	-46.54M	-39.19M	-17.47M	-42.10M	-39.02M	-33.49M	-28.79M	-25.81M	-26.30M	-31.50M
Net Debt	-16.99M	-30.69M	-46.99M	-62.13M	-48.05M	-67.13M	-74.72M	-84.25M	-102.92M	-119.17M	-126.55M	-37.60M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2023-08-07Purchase

Owner: Commodore, Capital Lp

Title: -

Shares: 775,756

Price/Share: $23.15

Value: $17,958,751.40

Shares Owned: 1,575,000

Relationship: TenPercentOwner

Ownership: Indirect

2022-08-18Purchase

Owner: Gin, Jerry B

Title: -

Shares: 100,000

Price/Share: $0.18

Value: $18,000.00

Shares Owned: 100,000

Relationship: Director

Ownership: Direct

2022-08-17Purchase

Owner: Singh, Shawn

Title: CHIEF EXECUTIVE OFFICER

Shares: 600,000

Price/Share: $0.17

Value: $102,000.00

Shares Owned: 626,234

Relationship: Director,Officer

Ownership: Indirect

2022-08-17Purchase

Owner: Adler, Reid G.

Title: CHIEF LEGAL OFFICER

Shares: 300,000

Price/Share: $0.17

Value: $51,000.00

Shares Owned: 334,629

Relationship: Officer

Ownership: Direct

2022-07-12Sale

Owner: Vhcp, Management Ii, Llc,…

Title: -

Shares: 60,000

Price/Share: $0.89

Value: $53,400.00

Shares Owned: 20,637,286

Relationship: TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2023-08-07	Commodore, Capital Lp	TenPercentOwner	-	Indirect	Purchase	775,756	23.15	$17,958,751.40	1,575,000	4
2022-08-18	Gin, Jerry B	Director	-	Direct	Purchase	100,000	0.18	$18,000.00	100,000	4
2022-08-17	Singh, Shawn	Director,Officer	CHIEF EXECUTIVE OFFICER	Indirect	Purchase	600,000	0.17	$102,000.00	626,234	4
2022-08-17	Adler, Reid G.	Officer	CHIEF LEGAL OFFICER	Direct	Purchase	300,000	0.17	$51,000.00	334,629	4
2022-07-12	Vhcp, Management Ii, Llc,…	TenPercentOwner	-	Indirect	Sale	60,000	0.89	$53,400.00	20,637,286	4
2021-09-07	Dotson, Jerrold Duane	Officer	VP, CFO AND SECRETARY	Direct	Sale	30,000	3.13	$93,900.00	72,786	4
2021-08-17	Snodgrass, H. Ralph	Officer	PRES./CHIEF SCIENTIFIC OFFICER	Indirect	Purchase	3,750	2.73	$10,237.50	34,641	4
2020-08-21	Saxe, Jon S	Director	-	Indirect	Purchase	30,000	0.69	$20,700.00	50,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

36.67%

Inst. Shares: 13,961,650

Shares Outstanding: 38,073,926

2025-12-31

32.20%

Inst. Shares: 13,600,106

Shares Outstanding: 42,234,405

2025-09-30

65.25%

Inst. Shares: 23,326,158

Shares Outstanding: 35,749,160

2025-06-30

48.38%

Inst. Shares: 15,447,284

Shares Outstanding: 31,930,665

2025-03-31

51.62%

Inst. Shares: 15,938,750

Shares Outstanding: 30,877,029

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	13,961,650	38,073,926	36.67%
2025-12-31	13,600,106	42,234,405	32.20%
2025-09-30	23,326,158	35,749,160	65.25%
2025-06-30	15,447,284	31,930,665	48.38%
2025-03-31	15,938,750	30,877,029	51.62%
2024-12-31	15,514,601	30,711,872	50.52%
2024-09-30	15,214,965	30,632,347	49.67%
2024-06-30	13,607,208	30,603,435	44.46%
2024-03-31	14,427,801	19,354,500	74.54%
2023-12-31	14,846,509	29,388,085	50.52%
2023-09-30	2,952,170	10,042,530	29.40%
2023-06-30	763,307	7,337,005	10.40%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Vistagen Therapeutics, Inc. (VTGN) — SEC Financial Statements & Analysis

Vistagen Therapeutics, Inc. (VTGN) is a pharmaceutical preparations company, incorporated in NV. Vistagen Therapeutics, Inc. trades on Nasdaq as: VTGN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Vistagen Therapeutics, Inc. reported a 287.15% year-over-year revenue growth, a Debt-to-Equity ratio of 0.46x, a Price-to-Sales (P/S) ratio of 3.95x (TTM), a Price-to-Book (P/B) ratio of 0.40x (TTM), at a market cap of $9.89M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 287.15%
Debt To Equity: 0.46x
P/S TTM: 3.95x
P/B TTM: 0.40x
Market Cap: $9.89M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Vistagen Therapeutics, Inc. in?

Vistagen Therapeutics, Inc. (VTGN) operates in the Pharmaceutical Preparations industry.

What is VTGN's market cap?

Vistagen Therapeutics, Inc. (VTGN) has a market capitalization of $9.89M as of 2026-06-30.

What exchange does VTGN trade on?

Vistagen Therapeutics, Inc. (VTGN) trades on the Nasdaq.

Where is Vistagen Therapeutics, Inc. incorporated?

Vistagen Therapeutics, Inc. is incorporated in NV.